SEC Form D · filed July 14, 2021
Prellis Biologics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (14)
Michael Marks · Hayward, CADirectorAlex Morgan · Hayward, CADirectorShaun Holt · Hayward, CADirectorMelanie Matheu · Hayward, CAExec · DirectorJoseph A. Bergida · Olathe, KSExec · DirectorDuane Lo · Vancouver, British Columbia, CanadaDirectorMichael Blady · Vancouver, British Columbia, CanadaDirectorJohn R. Bergida · Ballwin, MODirectorArvind Gupta · Hayward, CADirectorJack T. Conti · Richmond, VADirectorAshwini S. Obulreddygari · Frisco, TXDirectorMichael Malafronte · New York, NYDirectorBrian J. O'Connor · New York, NYExec · DirectorArvind Gupta · San Francisco, CADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗